Kenya Alzheimer’s Therapeutics Market Analysis

Kenya Alzheimer’s Therapeutics Market Analysis


$ 3999

Kenya alzheimer’s therapeutics market valued at $3 Mn in 2022, projected to reach $7 Mn by 2030 with a 10.2% CAGR. The growing prevalence of Alzheimer's disease, which is fuelled by an aging population, is the main factor driving the market for drugs used to treat the condition. The leading pharmaceutical companies currently working in the industry are Eisai, Biogen, GlaxoSmithKline, Novartis, Pfizer, Roche, Johnson & Johnson, Eli Lilly, AstraZeneca and Merck & Co.

ID: IN10KEPH431 CATEGORY: Pharmaceuticals GEOGRAPHY: Kenya AUTHOR: Dr. Medha Sansanwal

Buy Now

Kenya Alzheimer’s Therapeutics Market Executive Summary

Kenya alzheimer’s therapeutics market valued at $3 Mn in 2022, projected to reach $7 Mn by 2030 with a 10.2% CAGR.

Alzheimer's disease is a neurological disorder that negatively impacts mental health, behavior, and memory. This illness usually starts slowly, worsens with time, and makes it harder for the affected person to carry out daily duties. The disorder is characterized by aberrant alterations in the brain, including the development of plaques and tangles, which ultimately result in the loss of nerve cells. As of right now, there is no proven treatment for Alzheimer's disease; but some drugs can help manage symptoms and improve quality of life. The medications, which include memantine, rivastigmine, and donepezil, alter particular neurotransmitters in the brain to treat memory and cognitive issues. Non-pharmacological methods that may aid in the overall management of a condition include creating a supportive atmosphere, taking part in social and cognitive activities, and leading a healthy lifestyle.

Kenya's population is rapidly aging, contributing to a significant demographic shift that will see the proportion of adults over 60 double by 2050. This age group's greater susceptibility to Alzheimer's disease, a disorder linked to cognitive loss and higher mortality, is concerning given the demographic trend. In Kenya, 1,827 deaths were attributable to dementia and Alzheimer's disease, accounting for 0.69% of all deaths. With an age-adjusted death rate of 18.35 per 100,000 people, Kenya is ranked 76th in the world. These figures highlight how important it is becoming to prioritize Alzheimer's disease care in Kenya, which calls for proactive approaches to prevention, more public awareness, and improved infrastructure for healthcare that is suited to the unique requirements of the country's aging population.

A significant event occurred in October 2023 when the US Food and Drug Administration (FDA) approved Lecanemab, a novel Alzheimer's medication that Eisai and Biogen co-developed. This approval represents a major advancement in the area even though the drug is not yet available in Kenya. It may pave the way for the introduction of similar drugs through licensing or local development in the future. Meanwhile, organizations like the Alzheimer's & Dementia Organisation Kenya (ADOK) are working hard to raise awareness of Alzheimer's, stress the importance of early identification, and push for improved patient access to healthcare services. This group's endeavor demonstrates a dedication to tackling the complexity of Alzheimer's disease locally and globally.

Kenya alzheimer's therapeutics market

Market Dynamics

Market Growth Drivers

Rising Burden of Alzheimer's Disease: Alzheimer's disease risk is rising in Kenya due to the country's fast aging population, with 5.3 Mn people over 60 expected to exist by 2030. This shift in the population is correlated with an increased prevalence of age-related illnesses, like Alzheimer's disease. As more and more older people are developing Alzheimer's disease, there is a growing need for effective interventions. This demographic trend is a strong driver of market expansion.

Emerging Treatment Options: Late-stage clinical research on Alzheimer's therapy has yielded exciting advances that address many aspects of the illness and offer promise for improved treatments. The Tau protein aggregation-focused Etermis clinical study for EMERG-01 is an illustration of how local initiatives can improve global healthcare and eventually support the expansion of the Alzheimer's medication market.

Increased Awareness and Diagnosis: Growing public awareness of Alzheimer's disease and improved diagnostic tools are crucial for early diagnosis and timely treatment start, which increases the number of patients actively looking for effective drugs. Government initiatives to improve accessibility to diagnostic services and raise public awareness also act as catalysts for industry expansion. Together, these calculated moves create an atmosphere that supports early intervention and increases the market's need for efficacious pharmaceutical solutions, which contributes to the market's growth.

Market Restraints

Complex regulatory processes: Pharmaceutical companies face a challenging task in navigating the medication approval process, which could impede the nation's efforts to develop Alzheimer's disease medicines. Encouraging new participants with support systems and simplifying regulations may serve as stimulants and foster an environment that is conducive to innovation. Notably, one major market limitation that may deter pharmaceutical companies from actively researching and developing Alzheimer's medications is the complex and demanding regulatory environment.

High Drug Costs: The high cost of the current generation of Alzheimer's medications places a significant financial strain on both patients and their families. Due to the financial burden, getting treatment is more difficult for the general population, particularly for those with low incomes or inadequate insurance. This creates a considerable barrier to the market.

Low Public Awareness: Alzheimer's disease is stigmatized, and there is a lack of understanding about the disease's symptoms and potential treatments, which can lead to a delayed diagnosis and missed possibilities for prompt intervention. The importance of public education campaigns and awareness efforts in reducing these issues must be emphasized. Moreover, the prevalent deficiency in knowledge and comprehension leads to a significant market constraint that impedes the implementation of efficacious interventions and demands heightened efforts to educate the public and medical professionals.

Healthcare Policies and Regulatory Landscape

In Kenya, healthcare policies and regulatory bodies responsible for guaranteeing the safety, effectiveness, and accessibility of medications are in charge of monitoring and controlling treatment drugs. The primary regulatory agency responsible for the approval, registration, and oversight of pharmaceuticals in the nation is the Pharmacy and Poisons Board (PPB), which was founded under the Pharmacy and Poisons Act. Treatment medications are subjected to a stringent evaluation by the PPB before being approved for use and distribution in Kenya. Kenyan healthcare policy aims to achieve a balance between protecting the public's health and enabling prompt access to necessary drugs. The effectiveness of regulatory processes and the accessibility of treatment medications, however, can be impacted by issues including bureaucratic procedures and resource constraints.

Competitive Landscape

Key Players

  • Eisai
  • Biogen
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Roche
  • Johnson & Johnson,
  • Eli Lilly
  • AstraZeneca
  • Merck & Co.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Kenya Alzheimer’s Therapeutics Market Segmentation

By Type

  • Early-Onset Alzheimer's
  • Late-Onset Alzheimer's
  • Familial Alzheimer's disease

By Drug Name

  • Donepezil
  • Rivastigmine
  • Memantine
  • Galantamine
  • Manufactured a combination of memantine and donepezil

By Drug Class

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Manufactured Combination

By End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Drug stores
  • Retail pharmacies
  • Online pharmacies
  • Other distribution channel

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 09 April 2024
Updated by: Jay Dalwadi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up